Advances in Clinical Chemistry
- 1st Edition, Volume 81 - June 20, 2017
- Editor: Gregory S. Makowski
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 1 2 0 7 4 - 3
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 2 1 7 7 - 1
Advances in Clinical Chemistry, Volume 81, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laborator… Read more
Purchase options
Advances in Clinical Chemistry, Volume 81, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. New to this latest release are chapters that cover Microparticles in Chronic Heart Failure, Peptide Antibodies in Clinical Laboratory Diagnostics, Measurement and Clinical Utility of βCTX in Serum and Plasma, Human Papillomavirus and its Testing Assays, Cervical Cancer Screening, and Vaccination, and Physical Exercise and DNA Injury: Good or Evil? The serial presents the latest technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians and research scientist
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Clinical Laboratory Professionals, Physicians and Research Scientists
1. Microparticles in Chronic Heart FailureA.E. Berezin2. Peptide Antibodies in Clinical Laboratory DiagnosticsN.H. Trier and G. Houen3. Measurement and Clinical Utility of βCTX in Serum and PlasmaS.A.P. Chubb and S.D. Vasikaran4. Human Papillomavirus and its Testing Assays, Cervical Cancer Screening, and VaccinationY. Zhu, Y. Wang, J. Hirschhorn, K.J. Welsh, Z. Zhao, M.R. Davis and S. Feldman5. Physical Exercise and DNA Injury: Good or Evil?E. Danese, G. Lippi, F. Sanchis-Gomar, G. Brocco, M. Rizzo, M. Banach and M. Montagnana6. Bulky DNA Adducts, Tobacco Smoking, Genetic Susceptibility and Lung Cancer RiskA. Munnia, R.W. Giese, S. Polvani, A. Galli, F. Cellai and M.E.M. Peluso
- Edition: 1
- Volume: 81
- Published: June 20, 2017
- Language: English
GM
Gregory S. Makowski
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USARead Advances in Clinical Chemistry on ScienceDirect